REACTIVITY OF RENAL AND SYSTEMIC CIRCULATIONS TO VASOCONSTRICTOR AGENTS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS
(Submitted for publication June 13, 1961 ; accepted August 31, 1961) It has been suggested that vascular hyper-reactivity is in part responsible for the vasoconstriction in human essential hypertension. This thesis has been examined by comparing the response to vasoconstrictor agents in hypertensive patients with that of normotensive subjects.
Kylin (1), Brems (2), Gordon and Levitt (3), Fatherree and Hines (4), Judson and co-workers (5, 6) , and Barany and James (7) failed to demonstrate increased sensitivity to epinephrine or norepinephrine as measured by systemic blood pressure response in hypertensive patients.
Goldenberg and associates (8) found no increased response to norepinephrine in hypertensive patients at high dosage but the response was somewhat increased at lower dosage. However, increased response of systemic blood pressure to epinephrine and norepinephrine in hypertension was reported by Clough (9), Jensen (10) , and Doyle and Black (11) .
In evaluating sensitivity of local vascular beds of the extremities to epinephrine by calorimetric or plethysmographic methods, Pickering and Kissin (12) and Prinzmetal and Wilson (13) found no increased response in hypertensive patients. Contrariwise, Mendlowitz and Naftchi (14) , Barany and James (7) , and Doyle, Fraser and Marshall (15) reported increased reactivity in hypertension; Duff (16) reported no increased sensitivity to epinephrine in "benign hypertension" but increased reactivity in "progressive or malignant hypertension." Greisman (17) found that the capillary bed of the nailfold of patients with essential hypertension was hyperreactive to infused l-norepinephrine. In normotensive subjects several investigators (18) (19) (20) have shown that epinephrine and l-norepinephrine produce reduction in renal plasma flow without affecting glomerular filtration rate. However, sensitivity of the renal vascular bed to epinephrine and l-norepinephrine has not been studied in subjects with essential hypertension.
The relationship of sodium intake to blood pressure levels in hypertensive patients has suggested the possibility that vascular resistance and reactivity may be affected by sodium content of the body or, specifically, the vessel wall. Raab and colleagues (21) observed a weakened or abolished pressor effect of infused epinephrine and i-norepinephrine in hypertensive patients on a rice diet. Aleksandrow and co-workers (22) , induced salt depletion in hypertensive subjects by administration of chlorothiazide, and also observed reduction of the pressor effect of infused l-norepinephrine. Dahl (23) , on the other hand, failed to demonstrate a uniform decrease in pressor response to i-norepinephrine after sodium depletion accomplished by dietary restriction in hypertensive patients. None of these studies dealing with the effect of sodium depletion on vascular reactivity includes observations on renal hemodynamics.
This paper deals with observations on the vasoconstrictor effect of infused epinephrine and i-norepinephrine on the renal and systemic circulations in normotensive and hypertensive subjects during normal sodium intake as well as after a period of dietary sodium restriction. The data demonstrate that renal and systemic arteriolar vasoconstrictor reactivity is equal in normotensive and hypertensive subjects as shown by an equal relative in- 152  530  157  505  154  445  147  435   133   773  132  610  129  530  118  460  121  435  131  447   147  888  141  641  143  521  119  403  113  355   134  739  ,139  636  130  506  128  464  129  426  136  425   150  641  141  511  136  410   134  719  140  623  135 78   86  110   93  100  104  72  105  72  113  66   83  80  119  72  124  60  137  56  155  47   79  80  91  74  105  70  75  120  68  148  70   93  78  119  66  131  56  142  52  147  50   81  64  92  62  103  61  119  60  119  59  126  58   91  81  108  67  140  51   107  84  114  82  125 early stages of their disease, as judged by the absence of proteinuria and by minimal retinal and cardiac abnormalities.
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The effect of l-norepinephrine on systemic blood pressure and renal hemodynamics was examined in 13 normotensive and 7 hypertensive subjects, and of epinephrine in 5 normotensive and 10 hypertensive subjects on a regular diet with normal salt content (10 to 15 g sodium chloride per day). The effect of l-norepinephrine during restricted dietary intake of salt (250 mg sodium chloride per day) was examined in 3 of the normotensive and 3 of the hypertensive subjects and of epinephrine in 4 of the normotensive and 5 of the hypertensive subj ects. Adherence to the regimen was verified by measurement of 24-hour urinary sodium excretion rates.
Fluids were withheld for 12 hours preceding the test, which was performed in the morning with the patient in the fasting state. Urine was collected from an indwelling catheter and the bladder was emptied by means of air and without washout. Surgical sterility was maintained throughout the test, and an antibiotic was administered for 5 days following the test.
After the injection of suitable priming doses of inulin and p-aminohippurate, a sustaining infusion of these substances dissolved in normal saline was administered at a rate of 2 ml per minute. Urine was collected during one to three periods totalling 30 to 45 minutes for the determination of glomerular filtration rate (GFR) and renal plasma flow (RPF). Thereafter an infusion of l-norepinephrine or epinephrine in concentrations of 1.5 ,ug per ml in 5 per cent dextrose in distilled water was administered at successively increasing rates, starting at approximately 2.5 ,Ag per minute. In most of the normotensive subjects the dosage of l-norepinephrine or epinephrine was increased to approximately 30 ,ug per minute, but in hypertensive subjects adverse manifestations such as substernal pressure, throbbing headache, palpitation or cardiac arrhythmia precluded administration of doses much in excess of 10 ,ug per minute. A separate urine collection was made to correspond with each dosage of vasoconstrictor. At appropriate time intervals blood samples were drawn from an antecubital vein, centrifuged immediately, and the plasma stored in stoppered tubes. Systemic blood pressures were recorded every 3 to 5 minutes throughout the study by the auscultatory method and averaged for each period. The mean blood pressure (Pm) was calculated as one-third of pulse pressure plus the diastolic pressure. Renal resistance (RR) was calculated according to the method of Gomez (24) . Inulin was determined by a modification of Harrison's method, and p-aminohippurate by the method of Smith (25) . Urinary sodium concentrations were measured with a flame photometer using lithium as an internal standard.
The observed values for GFR, RPF, Pm and RR in each subj ect were plotted against dosage of vasoconstrictor and the values for doses of 2.5, 5 ies performed during restricted dietary intake of salt because of the small number of subjects.
The observed values for all doses administered are presented in Tables I, II, IV -5 and Tables III,  VI and VII) of the three hypertensive patients, salt restriction increased the effect of l-norepinephrine on RR; this increased response in RR resulted from greater increase in Pm rather than from decrease in RPF. Salt restriction had no consistent effect on the response of RR to epinephrine in either normotensive or hypertensive subjects. DISCUSSION Our data demonstrate that the renal vasoconstrictor response to i-norepinephrine and epinephrine, measured as per cent change in renal resistance, is the same in normotensive and hypertensive subjects. Comparison of arteriolar reactivity in normotensive and hypertensive subjects necessitates interpreting changes produced in the resistance of arterioles that differ in initial circumference and initial degree of vasoconstriction, and that differ structurally as regards smooth muscle mass and sclerosis.
A given decrease in vessel circumference will result in a greater decrease in cross-sectional area (or increase in resistance) in a smaller (hypertensive) vessel than in a larger (normotensive) one. This disproportionate effect on renal resistance of given amounts of arteriolar muscle shortening may best be taken into account by comparing percentage rather than absolute changes in renal resistance. The proportional increases in renal resistance observed in the two groups in response to l-norepinephrine and epinephrine indicate that the actual circumference of the renal arterioles decreased to a greater extent in normotensive subjects, despite the fact that the absolute increase in renal resistance was greater in hypertensive patients.
The percentile method of comparison also takes into account the fact that the initial degree of preexisting vasoconstriction affects arteriolar reactivity; i.e., a less constricted vessel would be expected to respond by greater shortening than the more constricted vessel. Although Folkow and Oberg (26) reported that percentage increase in flow resistance in the hind limb of a cat is less in constricted vessels than in normal or dilated ones in response to norepinephrine or angiotensin, we doubt that data obtained in anesthetized cats, in which variations in initial vascular tone were induced by bilateral carotid artery occlusion or vagal stimulation, can be used to interpret relative reactivity in normotensive and hypertensive man.
The muscle mass of the renal vasculature might also affect comparison of reactivity to vasoconstrictor agents. It would seem reasonable to expect that a vessel with hypertrophied muscle fibers would respond with greater constriction even though reactivity of individual muscle fibers was not greater than normal. The failure of hypertensive patients to respond to a greater extent than do normotensive subjects, despite the presence of muscular hypertrophy in the former, supports the interpretation that reactivity to i-norepinephrine and epinephrine is not increased in hypertension.
The increased initial renal resistance in hypertensive subjects may be attributed to functional arteriolar constriction, anatomical narrowing, or both. Sclerotic changes in the vessel wall might decrease contractility and in this way interfere with the action of a vasoconstrictor agent. However, our studies are not significantly affected by such changes in the vessel wall, since patients were selected early in the course of hypertensive disease (as judged by history, clinical data, and the presence of only minimal reductions in RPF), indicating that functional vasoconstriction was predominantly responsible for the increased renal resistance.
A maximal limit to vasoconstriction in hypertensive patients might limit reactivity and in this way affect the comparison with normotensive subjects. The similarity of the curves for percentage change in renal resistance (Figures 4 and 5 ) throughout the dosage range of vasoconstrictors administered demonstrates that comparison of reactivity in normotensive and hypertensive subjects is not affected by such a ceiling.
Renal arteriolar reactivity to vasoconstrictor stimuli would be more profitably studied by employing an agent whose action is limited to the renal vascular bed. l-Norepinephrine increased systemic resistance and pressure in addition to its direct effect on the renal circulation and these systemic changes of themselves may induce renal vasoconstriction. However, unless the effect on the renal circulation of comparable changes in systemic pressure differs in normotensive and hypertensive subjects, the possible influence of systemic pressure on renal resistance should not limit the comparison of renal arteriolar reactivity in the two groups. Epinephrine did not affect mean systemic pressure, and here the changes in renal resistance may be interpreted unequivocally as reflecting the direct effect of the vasoconstrictor agent on the renal vessels.
Assuming that cardiac output is affected similarly in the hypertensive and normotensive subjects by both epinephrine and l-norepinephrine, as has been reported by Goldenberg and associates (8) , our observations indicate that the reactivity of the systemic vessels to epinephrine and I-norepinephrine is the same in normotensive and hypertensive subjects, since relative changes in systemic pressure were equal in both groups. The observation that reactivity of the systemic arterioles is comparable in normotensive and hypertensive subjects does not support the thesis that essential hypertension is related to increased vascular sensitivity to circulating norepinephrine.
Confirming the observations of others (27) (28) (29) , sodium restriction for periods ranging from 1 to 4 weeks produced a decrease in both systemic pressure and renal plasma flow in hypertensive patients; these did not decrease in the normotensive subjects. Sodium restriction causes reduction in extracellular fluid and plasma volumes (28, (30) (31) (32) , and in cardiac output (31, 32) . These hemodynamic effects could account for the decreases in systemic pressure and renal plasma flow observed in the hypertensive patients. Decrease of renal plasma flow in hypertensive patients indicates that greater renal vasoconstriction occurred in the hypertensive than in the normotensive subjects, and may be explained by a difference in renal response to systemic changes induced by sodium restriction or may indicate that greater reductions in extracellular fluid volume and cardiac output occurred in hypertensive subjects. Our observation that sodium restriction produced greater weight loss in hypertensive than in normotensive subjects supports the latter possibility.
Restriction of sodium intake failed to decrease renal arteriolar reactivity to i-norepinephrine or epinephrine in both normotensive and hypertensive subjects. In fact, the response to i-norepinephrine was enhanced in both groups, the effect being relatively greater in normotensive than in hypertensive subjects. This enhanced renal vasoconstrictor response is unexplained, but may reflect differences in smooth muscle contractility associated with changes in sodium content or increased sensitivity to vasoconstrictor influences resulting from reduced circulating blood volume.
Tobian and Fox (33) have reported that there is a gain of sodium and a loss of potassium in the arterial wall in dogs during norepinephrine infusion and have suggested that these electrolyte shifts play a part in smooth muscle contractility. Friedman, Jamieson and Friedman (34) have demonstrated that smooth muscle tone and responsiveness to drug-induced contraction are enhanced in the rat when the ratio of extracellular to intracellular sodium concentration is reduced. The applicability of these observations to our results cannot be assessed inasmuch as we have no data relative to the effect of sodium restriction on the sodium gradient across the vessel wall in our patients. The fact that the reactivity of the renal circulation to l-norepinephrine was increased to a greater extent in normotensive than in hypertensive subjects during sodium restriction may be attributed to the initially greater vasoconstriction which had already been produced by sodium restriction in the latter.
CONCLUSIONS
1. Renal and systemic arteriolar vasoconstrictor reactivity is equal in normotensive and hypertensive subjects, as shown by equal relative increases in both renal resistance and systemic blood pressure in response to the administration of l-norepinephrine and epinephrine. This observation is contrary to the thesis that essential hypertension is related to increased vascular sensitivity to circulating norepinephrine.
2. Restricted sodium intake fails to decrease renal arteriolar vasoconstrictor reactivity to i-norepinephrine and epinephrine in either normotensive or hypertensive subjects.
